# Fluoxetine for Obsessive-Compulsive Disorder in Children and Adolescents With Bipolar Disorder

> **NCT00592852** · PHASE4 · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 13 (actual)

## Conditions studied

- Pediatric Bipolar Disorder
- Pediatric OCD

## Interventions

- **DRUG:** fluoxetine

## Key facts

- **NCT ID:** NCT00592852
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-12
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Slow subject recruitment.
- **Last updated:** 2025-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00592852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00592852, "Fluoxetine for Obsessive-Compulsive Disorder in Children and Adolescents With Bipolar Disorder". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00592852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*